Johnson & Johnson
Market cap $651.2B
$270.00
JNJ
$270.00
+0.00% today
Buy with €1M virtual cash · No real money
Johnson & Johnson (JNJ) is a publicly traded company listed on the XNYS. As of September 19, 2026, Invest's signal rates JNJ a Buy, with the stock up 52% over the past year. You can practice trading JNJ risk-free with €1,000,000 in virtual cash.
Key stats
As of September 19, 2026
Market Cap
$651.2B
Volume
16.4M
52-wk High
$281.07
52-wk Low
$173.33
Day High
$272.11
Day Low
$267.20
P/E (TTM)
31.32
Revenue (TTM)
$97.9B
EPS (TTM)
$8.62
Performance
1M
-1.2%
6M
+13.6%
1Y
+52.4%
Invest signal · JNJ
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
JNJ overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +5.2%Revenue
$25BEPS (diluted)
$2.27 per shareLatest JNJ news
Can AstraZeneca's Broad Pipeline Offset Recent Setbacks?
Zacks Investment Research · 12h ago
J&J Up 18% in Three Months: Buy, Sell or Hold the Stock?
Zacks Investment Research · 13h ago
Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks Investment Research · 1d ago
Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape
GlobeNewswire Inc. · 1d ago
The Stock Market Looks Shaky Right Now. History Says Dividend Growth Stocks Are Exactly What You Want to Own.
The Motley Fool · 2d ago
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023.
After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Employees
140,800
30-Day Win Rate · JNJ
13 days
10 days
Last 23 sessions
How to practice trading JNJ
- 1
Use the JNJ buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top JNJ traders on Invest
Full leaderboardFrequently asked questions
Is JNJ a good stock to buy right now?
As of September 19, 2026, Invest's signal rates JNJ a Buy, based on its price trend, valuation, and fundamentals (P/E around 31.3), with the stock up 52% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading JNJ risk-free first.
What is Johnson & Johnson's (JNJ) market cap?
Johnson & Johnson has a market capitalization of approximately $651.2B, on trailing-twelve-month revenue of about $97.9B.
How has JNJ stock performed?
JNJ is up 52% over the past year and up 14% over six months. Its 52-week range runs roughly from $173.33 to $281.07. Past performance doesn't predict future results.
How can I practice trading JNJ for free?
On Invest you get €1,000,000 in virtual cash and can buy JNJ at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare JNJ with peers